Shortening the treatment period has become a top priority within TB research but studies to date have been unsuccessful.
Rigor académico, oficio periodístico
Artículos sobre TB in Africa
Mostrando todos artículos
Antibiotics that were not originally earmarked to treat TB have shown the first signs of effectiveness and could be added to the much-needed arsenal of drugs to fight the deadly disease.
South African scientists have found a way to single out the problematic parts of the bacteria causing TB that results in drug resistance.
African scientists have developed and patented a test for TB that overcomes two major challenges with current methods: it delivers quick results and is much cheaper.
Principales colaboradores
-
Head of the Immunology Research Group at the Division of Molecular Biology & Human Genetics, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Stellenbosch University
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Postdoctoral research fellow in the MRC Centre for Tuberculosis Research, Stellenbosch University
-
Scientist with the Division of Molecular Biology and Human Genetics and Director of TASK Applied Science, Stellenbosch University
